• No results found

[PDF] Top 20 FORMULATION AND OPTIMIZATION OF CLOPIDOGREL BISULFATE IMMEDIATE RELEASE TABLET

Has 10000 "FORMULATION AND OPTIMIZATION OF CLOPIDOGREL BISULFATE IMMEDIATE RELEASE TABLET" found on our website. Below are the top 20 most common "FORMULATION AND OPTIMIZATION OF CLOPIDOGREL BISULFATE IMMEDIATE RELEASE TABLET".

FORMULATION AND OPTIMIZATION OF CLOPIDOGREL BISULFATE IMMEDIATE RELEASE TABLET

FORMULATION AND OPTIMIZATION OF CLOPIDOGREL BISULFATE IMMEDIATE RELEASE TABLET

... established. Clopidogrel bisulfate immediate release tablets were evaluated for accelerated stability studies at 40 ± 2°C / 75 ± 2 % RH ... See full document

14

FORMULATION AND OPTIMIZATION OF SUSTAINED RELEASE FLOATING GASTRO RETENTIVE TABLET OF NIFEDIPINE USING NATURAL POLYMER

FORMULATION AND OPTIMIZATION OF SUSTAINED RELEASE FLOATING GASTRO RETENTIVE TABLET OF NIFEDIPINE USING NATURAL POLYMER

... was Formulation and optimization of sustained release floating tablet of Nifedipine using natural ...sustained release matrix tablet using fenugreek a natural polymer, different ... See full document

12

FORMULATION AND OPTIMIZATION OF SUSTAINED RELEASE TABLET OF PREGABALIN

FORMULATION AND OPTIMIZATION OF SUSTAINED RELEASE TABLET OF PREGABALIN

... sustained release matrix tablet of pregabalin in order to achieve the prolonged therapeutic action by releasing the drug over an extended period of time after a single dose administration which would help ... See full document

10

Formulation and optimization of immediate release tablet of an anti hypertensive drug by dry granulation method

Formulation and optimization of immediate release tablet of an anti hypertensive drug by dry granulation method

... The present study is planned to develop Candesartan cilexetil into immediate release tablets. Generally dry granulation is followed for the drugs that are sensitive to the moisture .Here the dry granulation ... See full document

8

FORMULATION DEVELOPMENT AND OPTIMIZATION OF OLMESARTAN MEDOXOMIL IMMEDIATE RELEASE TABLETS

FORMULATION DEVELOPMENT AND OPTIMIZATION OF OLMESARTAN MEDOXOMIL IMMEDIATE RELEASE TABLETS

... conventional immediate release formulations provide clinically effective therapy while maintaining the required balance of pharmacokinetic and pharmacodynamic profiles with an acceptable level of safety to ... See full document

6

FORMULATION AND EVALUATION OF CLOPIDOGREL BISULFATE  IMMEDIATE RELEASE TABLETS

FORMULATION AND EVALUATION OF CLOPIDOGREL BISULFATE IMMEDIATE RELEASE TABLETS

... improved formulation of Clopidogrel bisulphate immediate release ...developing immediate release tablet is accomplished by using a suitable diluents and ...the ... See full document

13

Formulation, Optimization and Evaluation of Clarithromycin Immediate Release Film Coated Tablet

Formulation, Optimization and Evaluation of Clarithromycin Immediate Release Film Coated Tablet

...  Drug/PLA microspheres were prepared by solvent evaporation and recovered by filtration or spray-drying. Variations in processing parameters, e.g., polymer concentration in the dispersed phase, type of continuous phase ... See full document

156

Formulation and process optimization of Etodolac extended release tablet

Formulation and process optimization of Etodolac extended release tablet

... The distribution of Etodolac is well acceptable at 25 minutes (Pre lubrication) and 30 minutes (Final blending) time as shown by the sample analyzed, which indicates the homogeneciity of drug distribution in the blending ... See full document

6

Design development and optimization of immediate release tablet of valsartan

Design development and optimization of immediate release tablet of valsartan

... Preliminary batches of IRT of valsartan were prepared by direct compression method employing sodium starch glycolate and Ac-Di-Sol as superdisintegrants. Directly compressible Avicel PH 101, was used as diluent. A total ... See full document

5

Design, development and optimization of immediate release tablet of deflazacort

Design, development and optimization of immediate release tablet of deflazacort

... It can be concluded from the present study that using appropriate concentration of superdisintegrant SSG and Ac- Di-Sol IRT can be formulated with acceptable values of disintegration time and friability. Addition of ... See full document

5

DEVELOPMENT AND OPTIMIZATION OF IMMEDIATE RELEASE TABLET OF FEBUXOSTAT IN GOUT TREATMENT

DEVELOPMENT AND OPTIMIZATION OF IMMEDIATE RELEASE TABLET OF FEBUXOSTAT IN GOUT TREATMENT

... Lactose Monohydrate(Pharmatose 200 M): DFE pharma Pvt Ltd; Microcrystalline Cellulose (Comprecel M 101D+): DFE pharma Pvt Ltd; Croscarmellose Sodium (Acdisol): Signetchemical corporation pvt Ltd; Hydroxy propyl cellulose ... See full document

10

FORMULATION DEVELOPMENT AND EVALUATION OF CLOPIDOGREL BISULFATE TRANSDERMAL PATCHES

FORMULATION DEVELOPMENT AND EVALUATION OF CLOPIDOGREL BISULFATE TRANSDERMAL PATCHES

... 0.93%. Optimization of the formulated patches was done by performing in-vitro drug release studies using Franz diffusion cell with cellophane ...drug release data and plot which were obtained for the ... See full document

6

Formulation and evaluation of trimetazidine hydrochloride and clopidogrel bisulphate multi unit solid dosage forms

Formulation and evaluation of trimetazidine hydrochloride and clopidogrel bisulphate multi unit solid dosage forms

... act. Clopidogrel bisulfate plays a central role as a platelet inhibitor in acute coronary syndromes, interventional cardiology and in secondary prevention of ischemic events in patients with myocardial ... See full document

6

Comparative fasting bioavailability of two clopidogrel formulations in healthy Mediterranean volunteers: an in vitro–in vivo correlation

Comparative fasting bioavailability of two clopidogrel formulations in healthy Mediterranean volunteers: an in vitro–in vivo correlation

... study, both were tested. The validated analytical methods described above were used for quantification of clopidogrel and its main metabolite. The validated analytical methods provided appropriate accuracy, ... See full document

7

FORMULATION AND EVALUATION OF METFORMIN AND GLIMEPIRIDE BILAYERED TABLET

FORMULATION AND EVALUATION OF METFORMIN AND GLIMEPIRIDE BILAYERED TABLET

... drug release. Tablets with code no MF8 exhibited extended drug release up to 12 hr (Table 6 ...drug release was significant when HPMC K 15 M used as Matrix ...extended release of drug (Table 6 ... See full document

12

FORMULATION AND EVALUATION OF BILAYER TABLET OF NIACINAMIDE EXTENDED RELEASE AND AMLODIPINE BESYLATE IMMEDIATE RELEASE

FORMULATION AND EVALUATION OF BILAYER TABLET OF NIACINAMIDE EXTENDED RELEASE AND AMLODIPINE BESYLATE IMMEDIATE RELEASE

... all tablet formulations was found to be within the above limit, in compliance with official ...drug release of batch FA1 and FA7 containing MCC and di-Calcium phosphate as a immediate release ... See full document

6

FORMULATION AND EVALUATION OF BILAYER TABLET OF AMBROXOL HCL AND DESLORATADINE FOR THE TREATMENT OF SEASONAL ALLERGIC RHINITIS ASSOCIATED WITH COUGH

FORMULATION AND EVALUATION OF BILAYER TABLET OF AMBROXOL HCL AND DESLORATADINE FOR THE TREATMENT OF SEASONAL ALLERGIC RHINITIS ASSOCIATED WITH COUGH

... and dry the granules in Fluidized Bed Dryer for 20 minutes. Now pass the granules through (sieves) mesh no. #16 and final pass the granules through (sieves) mesh no. #24. After passing the granules check the LOD of the ... See full document

13

Design and Characterization of Bilayer Tablet of Rifampicin and Isoniazid for Tuberculosis Therapy

Design and Characterization of Bilayer Tablet of Rifampicin and Isoniazid for Tuberculosis Therapy

... different release profiles which improves patient compliance, prolongs the drug(s) action, avoid saw tooth kinetics resulting in effective therapy along with better control of plasma drug levels 4 ... See full document

5

FORMULATION DEVELOPMENT AND EVALUATION OF METOPROLOL SUCCINATE SUSTAINED RELEASE AND HYDROCHLOROTHIAZIDE IMMEDIATE RELEASE BILAYER TABLET

FORMULATION DEVELOPMENT AND EVALUATION OF METOPROLOL SUCCINATE SUSTAINED RELEASE AND HYDROCHLOROTHIAZIDE IMMEDIATE RELEASE BILAYER TABLET

... Formulation of Hydrochlorothiazide Granules: Layer 2: Different formulations (F1-F6) were prepared with Lactose, microcrystalline cellulose, maize starch, colloidal silicon dioxide, and other excipients. The ... See full document

8

DESIGN AND IN VITRO EVALUATION OF BILAYER TABLET CONTAINING TWO INCOMPATIBLE ANTIHYPERTENSIVE DRUGS

DESIGN AND IN VITRO EVALUATION OF BILAYER TABLET CONTAINING TWO INCOMPATIBLE ANTIHYPERTENSIVE DRUGS

... Potassium immediate release granules: Sift the weighed quantity of losartan potassium, microcrystalline cellulose, calcium hydrogen phosphate, croscormellose sodium, feric oxide red, through mesh ... See full document

11

Show all 10000 documents...